113 related articles for article (PubMed ID: 25770192)
1. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer.
Baron B; Fujioka T; Kitagawa T; Maehara S; Maehara Y; Nakamura K; Kuramitsu Y
Cancer Genomics Proteomics; 2015; 12(2):83-7. PubMed ID: 25770192
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environment.
Baron B; Kitagawa T; Nakamura K; Kuramitsu Y
Cancer Genomics Proteomics; 2015; 12(2):49-55. PubMed ID: 25770187
[TBL] [Abstract][Full Text] [Related]
3. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
Kuramitsu Y; Taba K; Ryozawa S; Yoshida K; Zhang X; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2010 Sep; 30(9):3367-72. PubMed ID: 20944110
[TBL] [Abstract][Full Text] [Related]
4. Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.
Suenaga S; Kuramitsu Y; Wang Y; Baron B; Kitagawa T; Akada J; Tokuda K; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2013 Nov; 33(11):4821-6. PubMed ID: 24222118
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.
Kuramitsu Y; Suenaga S; Wang Y; Tokuda K; Kitagawa T; Tanaka T; Akada J; Maehara S; Maehara Y; Nakamura K
Anticancer Res; 2013 Aug; 33(8):3133-6. PubMed ID: 23898070
[TBL] [Abstract][Full Text] [Related]
6. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Mikuria K; Fujimoto M; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
Int J Oncol; 2007 Dec; 31(6):1345-50. PubMed ID: 17982661
[TBL] [Abstract][Full Text] [Related]
7. High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.
Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Akada J; Tokunaga M; Nakamura K
Anticancer Res; 2015 Jul; 35(7):3861-5. PubMed ID: 26124331
[TBL] [Abstract][Full Text] [Related]
8. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.
Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Mori-Iwamoto S; Maehara S; Maehara Y; Sakaida I; Nakamura K
Chemotherapy; 2011; 57(1):12-6. PubMed ID: 21124027
[TBL] [Abstract][Full Text] [Related]
9. Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.
Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2010 Jul; 30(7):2539-43. PubMed ID: 20682980
[TBL] [Abstract][Full Text] [Related]
10. Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells.
Maehara S; Tanaka S; Shimada M; Shirabe K; Saito Y; Takahashi K; Maehara Y
Int J Cancer; 2004 Nov; 112(2):184-9. PubMed ID: 15352029
[TBL] [Abstract][Full Text] [Related]
11. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
Suenaga S; Kuramitsu Y; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2014 Jan; 34(1):141-6. PubMed ID: 24403454
[TBL] [Abstract][Full Text] [Related]
12. Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action.
Baron B; Wang Y; Maehara S; Maehara Y; Kuramitsu Y; Nakamura K
Anticancer Res; 2015 Apr; 35(4):1941-9. PubMed ID: 25862846
[TBL] [Abstract][Full Text] [Related]
13. Role of heat shock protein 27 in gemcitabine-resistant human pancreatic cancer: comparative proteomic analyses.
Liu QH; Zhao CY; Zhang J; Chen Y; Gao L; Ni CY; Zhu MH
Mol Med Rep; 2012 Oct; 6(4):767-73. PubMed ID: 22858734
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells.
Chen YW; Liu JY; Lin ST; Li JM; Huang SH; Chen JY; Wu JY; Kuo CC; Wu CL; Lu YC; Chen YH; Fan CY; Huang PC; Law CH; Lyu PC; Chou HC; Chan HL
Mol Biosyst; 2011 Nov; 7(11):3065-74. PubMed ID: 21894339
[TBL] [Abstract][Full Text] [Related]
15. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells.
Shimada T; Nanimoto Y; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
In Vivo; 2018; 32(4):759-763. PubMed ID: 29936456
[TBL] [Abstract][Full Text] [Related]
17. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells.
Wang Y; Kuramitsu Y; Baron B; Kitagawa T; Tokuda K; Akada J; Maehara SI; Maehara Y; Nakamura K
Int J Oncol; 2017 Feb; 50(2):606-612. PubMed ID: 28000865
[TBL] [Abstract][Full Text] [Related]
18. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.
Kuhara K; Tokuda K; Kitagawa T; Baron B; Tokunaga M; Harada K; Terasaki M; Uehara O; Ohta T; Takai R; Hamada JI; Kobayashi M; Shimo T; Nagayasu H; Kuramitsu Y
Anticancer Res; 2018 Nov; 38(11):6107-6111. PubMed ID: 30396925
[TBL] [Abstract][Full Text] [Related]
19. HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer.
Jakstaite A; Maziukiene A; Silkuniene G; Kmieliute K; Gulbinas A; Dambrauskas Z
World J Gastroenterol; 2015 Dec; 21(46):13004-19. PubMed ID: 26675757
[TBL] [Abstract][Full Text] [Related]
20. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
